High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
about
Autoimmune Myopathies: Where Do We Stand?Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy.Malignancy screening in autoimmune myositis amongst Australian Rheumatologists.Skeletal Muscle Involvement in Antisynthetase Syndrome.Integrated classification of inflammatory myopathies.Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer.High-dose cyclophosphamide without stem cell rescue in immune-mediated necrotizing myopathies.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.Anti-HMGCR autoantibodies in self-limiting statin-induced myopathy.A Case of Dermatomyositis Complicated by Digital Ischemia and Lung Adenocarcinoma in a Patient with Positive Anti-signal Recognition Particle Antibodies.More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.Immune-Mediated Necrotizing Myopathy.Anti-HMGCR Myopathy.Statin-induced myalgia and myositis: an update on pathogenesis and clinical recommendations.Editorial: A New Classification of Adult Autoimmune Myositis.Triggers of inflammatory myopathy: insights into pathogenesis.Current Classification and Management of Inflammatory Myopathies.Myopathy due to HMGCR antibodies in adult mimicking muscular dystrophy associated with cancer and statin exposure - narrative review of the literature - case report.Necrotizing Autoimmune Myopathy: Clinicopathologic Study from a Single Tertiary Care Centre.Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathyWhen Should a Patient with Statin-Induced Myopathy Be Re-challenged? A Case of Necrotizing Autoimmune Myopathy
P2860
Q26744554-76CBDA94-DC2E-4A0E-A9D1-5EB000CA7AA8Q37324573-08DBC6E4-44A0-4B50-A0F6-C399DE42718EQ38662460-5596B812-7CA1-4190-9E97-9E940BA09FB9Q38740583-62C6F5FE-B06F-41DC-B7CD-8219BB2A658FQ39027323-700B0162-1BA3-4764-BD8C-2733DB466CD2Q41485219-D183D2F4-AA83-48EE-82DF-D8F99F000799Q41814408-D486876A-570D-4CC1-84C9-50CF7DE51288Q42365042-9269D053-0E6A-4124-BB9C-F2CD5B7E8B5CQ47165421-0F8FBFE7-4910-42A1-B886-7638B81CA021Q48253771-E3D2943F-BF0B-4F06-9EB9-17502FE5623AQ48519769-36A0292E-7023-48DA-B752-6BAB138B4B85Q50948932-CE761448-AFAE-4AB1-9793-E7D5DA6F738BQ52628910-F9C7C4B8-0A5D-490B-BA04-16CCDABAA2D8Q52685678-29FACFCA-DBD1-4835-A4CB-09C3E56F4B61Q52688656-91BCBAC7-BBEB-409F-A505-B69647682743Q53375302-09FF0A57-8ED9-4688-A668-6D4C2FCD337BQ54248374-893A6490-B781-4D26-9ABF-6F2887B9CF4FQ54977148-7B6D3D5A-5D77-41EB-A9F5-68786135922AQ54978610-E32EDC4B-3C12-48F1-B0E3-4A47C6926F02Q55078027-1E37ABE0-F7FE-4EAE-87DB-D9FFA22C2705Q57814497-53C1974C-E1BC-459F-98A4-347F1C929BE0Q58589752-E6D83C67-AD27-4ADD-ADCD-AD115DB1F43B
P2860
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
High risk of cancer in autoimm ...... of myositis specific antibody.
@en
type
label
High risk of cancer in autoimm ...... of myositis specific antibody.
@en
prefLabel
High risk of cancer in autoimm ...... of myositis specific antibody.
@en
P2093
P2860
P50
P356
P1433
P1476
High risk of cancer in autoimm ...... of myositis specific antibody
@en
P2093
Alain Meyer
Anne-Marie Bouvier
Aude Rigolet
Aurelie Grados
Baptiste Hervier
Bruno Eymard
Emmanuelle Salort-Campana
Fabienne Jouen
Jean-Luc Charuel
Jeremy Keraen
P2860
P304
P356
10.1093/BRAIN/AWW054
P407
P577
2016-04-17T00:00:00Z